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Edited by Richard CogdellAbstract Resonance Raman spectroscopy was applied to mon-
itor the eﬀects of chloroquine (CQ) treatment on cultures of
Plasmodium falciparum trophozoites. A number of bands as-
signed to A1g and B1g modes characteristic of the haemozoin
aggregate are reduced in intensity in the CQ-treated cells, how-
ever, no bands from the CQ are observed. The intensity changes
are attributed to intermolecular drug binding of the CQ in a
sandwich type complex between ferriprotoporphyrin IX (FeP-
PIX) dimer units. It is postulated that the CQ binds via p–p
interactions between adjacent and orientated porphyrins thereby
disrupting the haemozoin aggregate and reducing excitonic inter-
actions between adjacent haems. The results show the potential
of Raman microscopy as a screening tool for FePPIX:drug inter-
actions in live cells.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Malaria is still considered tobe oneof themost deadly diseases
in theworld, aﬀecting over 500million people and causing over 1
milliondeaths per year [1]. Theparasite,Plasmodium falciparum,
invades the body via the bite of the female Anopheles mosquito
and undergoes the vertebrate host stages of its lifecycle. During
the intraerythrocytic stage haemoglobin is degraded inside the
digestive vacuole of the parasite into toxic free haem and dena-
tured globin [2,3]. The process of detoxiﬁcation involves the con-
versionof iron-protoporphyrin IX (FePPIX) to haemozoin, also
known as malaria pigment, which is an insoluble compound
located in the food vacuole of the parasite. Haemozoin is spec-
troscopically identical to its synthetic analogue b-haematin
[4,5], which is known to be an array of dimers linked through re-
ciprocal iron-carboxylate bonds to one of the propionate side
chains of an adjacent Fe(III)PPIX moiety [6]. Quinoline drugs
such as chloroquine, quinine andamodiaquine are thought to in-
hibit the FePPIX crystallisation by binding to monomeric or di-
mericFe(III)PPIX, resulting in the build upof toxic freeFePPIX
which can kill the parasite [7–10]. de Villiers et al. [10] propose a*Corresponding author. Fax: +61 3 9905 4597.
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doi:10.1016/j.febslet.2008.02.062model in which the spontaneously formed aqueous Fe(III)PPIX
dimer non-covalently interacts with the unligated faces of two
ﬁve-coordinateH2O/HO
Fe(III)PPIXmolecules, with the axial
H2O/HO
 ligands pointing outwards. Three models for drug–
FePPIX interactions have beenproposed.Theﬁrst involves inhi-
bition of the growth of the haemozoin crystal by chiral speciﬁc
binding of the drug to the corrugated surface of haemozoin
through the vinyl andmethyl groups located on the Fe(III)PPIX
surface [11]. In the secondmodel drug binding occurs via a sand-
wich complex to the face of the crystal through p–p interactions
[12]. In the third model quinoline drugs are thought to form p–p
interactionswith haematin l-oxo dimers ([Fe(III)PPIX]2O) [13].
This is thought to decrease the availability of monomeric haem-
atin (H2O/OH
Fe(III)PPIX) for incorporation into haemozoin
by shifting the equilibrium towards the l-oxo dimer [14]. It
should be noted however that the existence of a l-oxo dimer
form of haematin under the conditions of the digestive vacuole
has been questioned [10].
While several studies have applied spectroscopic methods to
investigate Fe(III)PPIX:drug interactions in solution [13,15]
and the solid state [16] hitherto no spectroscopic study has
investigated the eﬀect of drug treatment on single P. falcipa-
rum-infected red blood cells. Using polarisation-resolved reso-
nance Raman spectroscopy Frosch et al. [15] observed small
wavenumber shifts when CQ was mixed with haematin in solu-
tion, which further supports a non-covalent Fe(III)PPIX:drug
complex. Frosch et al. [17] recently reported UV resonance
Raman spectra of chloroquine under physiological conditions.
In this work mode assignment was performed by comparison
with Density Functional Theory (DFT) calculations which
suggested that the protonation states of chloroquine greatly
inﬂuence the molecular geometry, vibrational modes and
molecular orbitals important for p–p interactions with hae-
mozoin [17]. Near IR Surface Enhanced Raman Spectroscopy
(NIR-SERS) measurements [18] of a CQ–FePPIX complex
were compared with data for haematin and CQ alone. The
CQ–FePPIX complex indicated an interaction between the
quinoline ring of the drug and the porphyrin ring [18].
In this work, we combine Raman microscopy using 782 nm
excitation, with Principal Components Analysis (PCA) to
investigate the eﬀect of CQ treatment on the physical organisa-
tion of haemozoin within the digestive vacuole of P. falciparum
trophozoites. We present evidence that CQ has an eﬀect on the
molecular environment of haemozoin within a red blood cell
and provide the ﬁrst spectroscopic evidence of CQ interferingblished by Elsevier B.V. All rights reserved.
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such FePPIX:drug interactions in situ.Fig. 1. Resonance Raman spectra of haemozoin in live red blood cells,
and of dried samples of haematin and haematin l-oxo dimer using a
782 nm excitation wavelength. Inset: Brightﬁeld and resonance Raman
image of a P. falciparum-infected red blood cell. The spot represents
the region from which the Raman spectrum was collected.2. Experimental
2.1. Cell culture
P. falciparum (a CQ sensitive strain, D10) was maintained in contin-
uous culture using human erythrocytes obtained from the Red Cross
Blood Bank, Melbourne [19]. Parasitised erythrocytes were cultured
in complete culture medium (CCM) consisting of RPMI 1640 (GIBCO
BRL), 25 mM hydroxypiperazine-N 0-2-ethane sulfonic acid (HEPES,
Sigma, pH 7.4), 2 g/l sodium bicarbonate (AnalR) and 4 mM Gluta-
max (Invitrogen). This was supplemented with 0.16% glucose (AnalR),
0.21 mM hypoxanthine (Sigma), 22 lg/ml gentamycin (Sigma) and 4%
human serum and 0.25% Albumax I (GIBCO-BRL). The cultures were
kept at 37 C in a humidiﬁed atmosphere of 5% CO2, 1% O2 and 90%
N2. Synchronised cultures (5% parasitemia) of late ring stage para-
sites were treated for 20 h with 100 nM CQ. This concentration is suf-
ﬁcient to inhibit growth of the parasites by approximately 80% as
monitored by uptake of [3H]-hypoxanthine (data not shown). Infected
RBCs (10 ll) were suspended in 10 ml of 0.9% saline solution and were
placed in an 80 mm diameter glass aluminium sputter coated Petri
dish; this was over-coated with poly-L-lysine to adhere the blood cells
to the base of the dish. The experiment was repeated three times.
2.2. Raman microscopy
Raman spectra of control and CQ-treated P. falciparum-infected
erythrocytes were recorded as described previously [20,21]. When the
power is kept low and measurements are recorded in growth media
in a temperature regulated environment, live infected red blood cells
show no visible damage to the membrane or photo-decomposition of
the haemoglobin. The Renishaw system 2000 spectrometer used was
equipped with a 782 nm diode laser with 18 mW raw output power
and 3–4 mW power at the sample, a BH2-UMA Olympus optical
microscope and a Zeiss water immersion 60· objective. The instrument
was calibrated daily using the 520.5 cm1 band of a silicon wafer.
Raman spectra were recorded by focusing the laser directly on the
haemozoin pigment within the live infected red blood cells. For both
the control and the CQ incubated cells spectra were recorded from
30 diﬀerent cells. Raman spectra were recorded in the spectral range
1800–200 cm1 using a single 10 s exposure at 10% power. All spectra
were normalised to the m10 m(CaCm)asym B1g vibrational mode. Spectra
of haematin, haematin l-oxo dimer and chloroquine were derived by
averaging 30 spectra taken at various diﬀerent positions on several
crystals for each compound using a normal 50· objective.
2.3. Data analysis
PCA is a fundamental technique used in multivariate data analysis
and involves the decomposition of data into noise and structural com-
ponents. The dimensionality of the data set is reduced by plotting the
objects onto principal components (PCs) with each consecutive com-
ponent orthogonally positioned with respect to the previous PC. Each
PC gives rise to a percentage of variance in the data set, with the ex-
plained variance decreasing as the PC increases. A plot of the scores
along each PC (scores plot) allows diﬀerences and similarities to be eas-
ily recognised. Each score represents a single spectrum and is plotted as
a point on a two-dimensional axis and the position of each point is
dependent on the individual variance contribution of the spectrum to
each PC [16]. The loadings plot is used in conjunction with the scores
plot to identify the variables that induce the most variability in the data
set. In this work, we applied PCA to ascertain biological variability and
investigate the uptake of drugs in a population of P. falciparum tropho-
zoites. Two diﬀerent methodologies were used to minimize baseline af-
fects. Firstly, an Extended Multiplicative Scatter Correction (EMSC)
was applied to all data to remove physical aﬀects, primarily baseline
variation between spectra of each data set. Secondly, a second deriva-
tive with a 13 point Savitzky–Golay smoothing function was applied.
2.4. Materials and synthesis
The l-oxo dimer form of haematin was prepared by dissolving
haematin (Sigma–Aldrich) in aqueous base (0.1 M NaOH) and 10%
(v/v) pyridine to produce 15.6 mM haematin l-oxo dimer solution
[10,22]. The solution was characterised by its characteristic UV–VISspectroscopy [10,22]. The 15.6 mM haematin l-oxo dimer solution
was dried onto aluminium sputter coated slide and the characteristic
Raman band (m(Fe–Osym)) at 413 cm
1 was observed in the Raman
spectrum [23–26]. The solution was also dried onto a Golden Gate
Diamond attenuated total reﬂectance ATR accessory on a Bruker
Equinox FTIR spectrometer and spectra recorded at a resolution of
4 cm1. The band at 880 cm1 assigned to the IR masym (Fe–O–Fe)
absorbance conﬁrms the presence of the l-oxo dimer (data not shown).
Chloroquine diphosphate was purchased from Sigma–Aldrich.3. Results and discussion
The haemozoin crystal is readily located as a dark pigment
granule in brightﬁeld images of live infected red blood cells
(Fig. 1, inset). The spectrum from the region of the haemozoin
is compared with spectra of haematin and the haematin l-oxo-
dimer in Fig. 1. For comparative purpose the spectra are nor-
malised to the band designated m10(1623 cm
1). The mode
notation is based on that proposed by Abe et al. [27] for the
resonance Raman spectra of nickel octa-ethyl porphyrin;
where under the D4h symmetry point group the modes are des-
ignated m1–m9 for A1g, m10–m18 for B1g, m19–m26 for A2g, m27–m35
for B2g, and m36–m55 for Eu modes. The A1g modes are totally
symmetric while the B1g, A2g, B2g modes are non-totally sym-
metric. The Eu modes are IR and Raman active. The symmetry
of ferric high spin haems such as haemozoin, haematin and b-
hameatin is ideally C4v because the Fe atom is translocated out
of the porphyrin plane but the D4h notation is often adopted
by convention. The c symbol is used to designate out-of-plane
modes of which there are a number of categories which include
(1) out-of-plane wagging modes, (2) tilting, and (3) internal
folding of the pyrrole rings. The strong bands in the haemoz-
oin spectrum include the in-plane asymmetric stretch of the
porphyrin ring m10(m(CaCm)asym) at 1623 cm
1 and the in-plane
stretch of the vinyl group m11(m(CbCb)) at approximately
1552 cm1. Bands at 1570, 1376, 1238 and 972 cm1are as-
signed to m2(m(CbCb)), m4(m(pyrrole half-ring)sym), m42(d(CmH)),
and m46(d(pyrrole deform)asym), respectively, and are listed in
Table 1. Bands present at 796 and 753 cm1 are assigned to
Table 1
Band assignments for haemozoin, haematin l-oxo-dimer and haematin
Haemozoin (cm1) Haematin (cm1) l-oxo dimer (cm1) Assignment Symmetry term Vibrational mode
1623 1622 1618 m10 B1g m(CaCm)asym
1570 1568 1567 m2 A1g m(CbCb)
1552 1550 1551 m11 B1g m(CbCb)
– – 1387 – – msym(COO
)
1376 1372 1368 m4 A1g m(pyrrole half-ring)sym
1238 1241 1239 m42 Eu d(CmH)
972 971 973 m46 Eu d(pyrrole deform)asym
796 797 792 m6 A1g m(pyrrole breathing)
751 754 753 m15 B1g m(pyrrole breathing)
709 – – c15 B2u m(pyrrole fold)asym
678 678 – m7 A1g m(pyrrole deform)sym
– – 413 – – m(Fe–O)sym
343 – 341 m8 A1g m(Fe–N)
m = In-plane stretch, c = out-of-plane stretch, d = deformation mode, a, b and m refer to carbon positions on the porphyrin.
Fig. 2. Micro-Raman spectra, using 782 nm excitation of haemozoin
in untreated (control) and CQ-treated infected red blood cells. A
spectrum of a dried sample of chloroquine disphosphate (CQ) is shown
for comparison.
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712, 680 and 343 cm1are assigned to c15 (m(pyrrole fold)asym),
m7(m(pyrrole deform)sym) and Fe-ligand stretching modes [27].
In some controls and CQ-treated cultures an unassigned band
at 472 cm1 was observed, the origin of which is not under-
stood. Most of the bands reported above are also observed
in the haematin monomer and l-oxo dimer but are less intense
when compared with the normalisation band m10 (1623 cm
1)
and in some cases are slightly shifted. The intensities of the
Raman bands of the haematin monomer and l-oxo dimer rel-
ative to m10 are reduced compared to the bands for haemozoin.
The diﬀerences in spectral intensity may reﬂect diﬀerences in
p–p interactions between porphyrins in the crystalline array.
We have previously identiﬁed atypical resonance Raman
enhancement in haematin, haemozoin and b-haematin when
exciting with near-IR wavelengths including 780 and 830 nm
[28]. Bands assigned to totally symmetric A1g modes were dra-
matically enhanced relative to m10 (1623 cm
1). These bands
normally become enhanced when exciting into the Soret band
at 400 nm from a type A or Frank–Condon mechanism. The
enhancement was found to be stronger for haemozoin and
b-haematin compared to haematin. It was hypothesised that
energy in the form of an exciton can migrate throughout the
FePPIX array through the superposition of excited electronic
states in the aggregate. Excitonic interactions have been shown
to cause unusual Raman enhancement patterns [28] and mech-
anisms such as Aggregated Enhanced Raman Scattering
(AERS) have been put forward to explain such patterns [29–
36]. It was reasoned that anti-malarials that bond via p–p
interactions to FePPIX could in theory act as molecular spac-
ers and reduce the excitonic eﬀects in the porphyrin array. This
in-turn would manifest in the Raman spectrum as a reduction
in intensity of vibrational modes sensitive to the electron den-
sity of the porphyrin such as m4, which is referred to as the
‘‘electron density marker band’’ or the ‘‘oxidation state marker
band’’.
To test this hypothesis ring stage infected RBCs were incu-
bated in the presence or absence of 100 nM CQ for 20 h. This
caused an 80% decrease in parasite growth as determined by
uptake of [3H] hypoxanthine (data not shown). Fig. 2 presents
average Raman spectra from the region of the haemozoin crys-
tal in control (n = 30) and CQ-treated (n = 30) samples. The
average spectrum from the CQ-treated cells shows a distinct
reduction in the intensity of the A1g modes: 1570, 1376, 796,
678 cm1 and the B1g modes: 1552, 751 cm
1 when comparedwith the controls. This intensity reduction for some of these
modes is more easily seen in the bar graph presented in
Fig. 3. There is a consistent but small shift in some of the
Raman bands (Table 2) whilst m2, which remains at
1552 cm1, appears to broaden (6.8–7.4 cm1) in response to
the drug treatment. These changes in position, intensity and
the shape of the Raman bands following CQ treatment indi-
cate changes in molecular environment of the malaria pigment
upon drug interaction. It is interesting to note the sensitivity of
the so called ‘‘electron density marker band’’, m4 to the drug
treatment. The position of this band is thought to be sensitive
to oxidation state [37]. In this case the relative intensity of m4
may be an indicator of the strength of p–p interactions. The
other band that appears sensitive to electron density is the
other A1g mode m2 at 1552 cm
1. Fig. 4a shows the diﬀerence
spectrum calculated from the average spectra presented in
Fig. 2. The diﬀerence spectrum shows a number of derivative
like features associated with changes in intensity, position
and width of haemozoin bands including the A1g and B1g
modes.
PCA was applied to ascertain the spectral variance within
the population of cells and detect underlying patterns within
the data. In the PC1 versus PC2 scores plot each spectrum is
represented as a point plotted on a set of PC orthogonal axes
Fig. 3. Plot of intensities (relative to the 1622 cm1 band for A1g and
B1g vibrational modes for haemozoin in control and CQ-treated
infected red blood cells.
Table 2
Raman band shifts and broadening for haemozoin from control and
CQ-treated red blood cell
Control (cm1) CQ aﬀected (cm1)
1623 1626
1552a 1552a
1376 1378
796 799
709 712
aBand broadening.
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ysis was performed on second derivative data from control and
drug inoculated cells. The PC1 versus PC2 scores plot showed
some separation (data not shown) but the ﬁrst PC explained
only 17% of the explained variance. An examination of the
loadings plot revealed strong loadings associated with the to-
tally symmetric A1g modes: 1567, 1370, 791, 675 cm
1 and
B1g modes at 1617 and 744 cm
1 (Fig. 4b). The loadings plotFig. 4. (a) Diﬀerence spectrum of the average spectra for haemozoin in CQ-tr
treated and control groups taken from the PCA scores plot (Fig. 3) along Pcorrelates well with the diﬀerence spectrum calculated using
the average spectra. The most extreme variables were selected
in Fig. 4b, as indicated by all the variables outside the dashed
lines, and the PCA was recalculated to reduce the noise level
and increase the explained variance along PC1. The resulting
scores plot (Fig. 5) shows a clear separation along PC1 be-
tween CQ-treated and control data sets. The explained vari-
ance for PC1 is 52% followed by 11% for PC2.
Previous studies [16] have supported the suggestion of p–p
stacking of quinoline drugs to malaria pigment. Solomonov
et al. [16] found that when quinine and chloroquine were
bound to b-haematin, the intensity of the bands attributed to
A1g modes appeared less intense compared to the controls
and there was a signiﬁcant degree of separation in PCA scores
plots for both data sets. The spectrum of chloroquine, itself, is
displayed in Fig. 2 and a vibrational assignment for all signif-
icant modes for chloroquine can be found in the work of Fro-
sch et al. [17]. The spectrum for haemozoin in the CQ-treated
infected red blood cells (Fig. 2) displays no peaks attributable
to chloroquine, probably because the concentration of chloro-
quine employed (100 nM) is too low to be detected within the
sensitivity limits of the Raman instrument. Hence there is no
simple direct evidence for drug binding to the surface of the
crystal. However, Solomonov et al. [16] show indirect evidence
of drug binding to the surface of b-haematin crystals using
IR-ATR analysis, where changes in what are hypothesised to
be surface propionic acid groups [14] are observed. An equiv-
alent band is not observed in the Raman spectrum because it is
not Raman active. Furthermore, there is no evidence of dis-
tinct Raman bands from the l-oxo dimer form of haematin
observed in the spectrum, in either control or CQ-treated sam-
ples.
The diﬀerences observed in the spectra for the CQ-treated
cells are subtle changes in the intensity and position of hae-
mozoin bands. The small shifts and intensity diﬀerences pro-
vide support for a model where the CQ binds between the
FePPIX dimer units and is held in place by p–p interactionseated and control infected red blood cell. (b) PCA loadings plot of CQ-
C1 after a 2nd derivative function was applied.
Fig. 5. PCA scores plot of control (0) and CQ-treated (j) infected red blood cell data sets taken from the PCA loadings plot (Fig. 4b) along PC1 of
the extreme variables.
Fig. 6. Model structure of a b-haematin dimer with the antimalarial drug chloroquine binding via p–p interactions of the quinoline rings to the
porphyrin rings of the Fe(III)PPIX.
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tially reduce the probability of intermolecular migration of en-
ergy in the form of an exciton throughout the crystal. This
model is supported by previous studies which show that CQ,
when mixed with haematin in solution, results in only small
wavenumber (cm1) shifts in the spectra [15]. Similar studies
on b-haematin (synthetic malaria pigment) coated with anti-
malarials (CQ and quinine) show a very clear separation in
the scores plot along PC1 [16]. The loadings plot for the
b-haematin/quinine data set also showed that the A1g and
B1g modes including (m10) 1626 cm
1, (m2) 1566 cm
1, (m2)
1551 cm1, (m4) 1372 cm
1, (m6) 797 cm
1 and (m7) 677 cm
1
are the modes aﬀected, again supporting a non-covalent p–p
drug binding orbital overlap mechanism.
Although previous IR-ATR [16] have shown that drug bind-
ing may aﬀect the surface propionic acid groups, there is no
evidence in the Raman spectrum of such a drug binding mech-
anism. Resonance Raman spectroscopy supports drug binding
via a sandwich complex through p–p orbital overlap to the face
of the crystal [12] within the digestive vacuole of the malarial
parasite. However, it does not rule out surface propionic acidgroup binding as a contributing mechanism because these
modes are not Raman active at near-IR excitation wave-
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